Skip to main content
Boston Scientific8-K: Margin pressure

Boston Scientific Q3 GAAP EPS drops to $0.40 from $0.51 following cybersecurity incident

Source: Autobound Signal API · 115 signals tracked for Boston Scientific · updated

Get Boston Scientific's live signals in Claude or ChatGPT, or by API

AskWhat changed at Boston Scientific this week? Use Autobound signals for bostonscientific.com.

What happened

Boston Scientific reported Q3 2026 GAAP net income of $582 million ($0.40 per share), down from $755 million ($0.51 per share) a year ago, noting challenges from an August 2026 cybersecurity incident. Sales and operational leaders may see budget pressure across affected business units or an increased willingness to optimize cost structures.

Source

SEC EDGAROct 28, 2026

Current report (Form 8-K)

Boston Scientific 8-K

Filing excerpt

The company reported GAAP net income attributable to Boston Scientific common stockholders of $582 million or $0.40 per share (EPS), compared to $755 million or $0.51 per share a year ago, and achieved adjusted EPS of $0.73 for the period, compared to $0.75 a year ago.

sec.gov/Archives/edgar/data/885725/000088572526000066/bsx-20261028.htmRead the full source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
8-K: Margin pressure

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
10/28
Filed
Oct 28, 2026

The full record

From the Signal API record

Numbers

Dollar figure
$582M (GAAP net income attributable to Boston Scientific common stockholders)

Details

CIK
885725
Accession number
0000885725-26-000066
Timeframe
Current quarter
Filing year
2026
Why it matters
Efficiency tools needed
Signal category
Financial

Extraction

Confidence
High
Relevance
75%
Sentiment
Negative
Detected
Nov 3, 2026
signal_type
sec-8k
signal_subtype
marginPressure

Use this data

Get every 8-K signal for Boston Scientific and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/c6671c7d-9e9d-4dda-b338-c6a6b4dda866 returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.

{
  "signal_id": "c6671c7d-9e9d-4dda-b338-c6a6b4dda866",
  "signal_type": "sec-8k",
  "signal_subtype": "marginPressure",
  "detected_at": "2026-11-03T07:15:52.227+00:00",
  "company": {
    "name": "Boston Scientific",
    "domain": "bostonscientific.com"
  },
  "data": {
    "detail": "Boston Scientific reported Q3 2026 GAAP net income of $582 million ($0.40 per share), down from $755 million ($0.51 per share) a year ago, noting challenges from an August 2026 cybersecurity incident. Sales and operational leaders may see budget pressure across affected business units or an increased willingness to optimize cost structures.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "GAAP net income attributable to Boston Scientific common stockholders",
      "dollar_millions": 582
    },
    "summary": "Boston Scientific Q3 GAAP EPS drops to $0.40 from $0.51 following cybersecurity incident",
    "excerpts": "The company reported GAAP net income attributable to Boston Scientific common stockholders of $582 million or $0.40 per share (EPS), compared to $755 million or $0.51 per share a year ago, and achieved adjusted EPS of $0.73 for the period, compared to $0.75 a year ago.",
    "relevance": 0.75,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000066/bsx-20261028.htm",
    "filing_date": "2026-10-28",
    "filing_year": 2026,
    "fiscal_year_end": "10/28",
    "sales_relevance": "Efficiency tools needed",
    "signal_category": "financial"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.